『HIMS Today - Jul 13: New Partners, FDA Meeting Buzz』のカバーアート

HIMS Today - Jul 13: New Partners, FDA Meeting Buzz

HIMS Today - Jul 13: New Partners, FDA Meeting Buzz

無料で聴く

ポッドキャストの詳細を見る
Hey, what’s up? It’s Joey here, your go-to guy for stock chatter. I’ve been investing for a while, and today we’re talking about Hims & Hers, or HIMS for short. It was a bit of a mixed bag today, barely up by about a third of a percent. Not a big move, but hey, at least it wasn’t a total flop.

So, what went down? HIMS is trying to shake things up with eight new partnerships, aiming to build this all-in-one health platform. Sounds cool, right? But here’s the kicker: they just had their worst week in two months. Ouch. They’re also gearing up for a big FDA meeting about their peptides campaign, which could be a game-changer for them.

Now, why the mixed vibes? Well, on one hand, those new partnerships are exciting and could signal growth, but on the flip side, there’s chatter about whether their GLP-1 strategy has backfired. That’s a fancy way of saying they might have bet on the wrong horse. Investors are probably feeling a bit jittery with all this back-and-forth.

And just to keep it real, the volume today was way off compared to their average. Like, they only had about 1.6 million shares traded when they usually see over 16 million. That tells me people might be sitting on the sidelines, waiting to see how this FDA meeting goes.

One thing worth keeping an eye on is that potential rally buzz. Some fund managers are saying HIMS could rally up to 60% this week if the stars align. I mean, that sounds great, but let’s keep those expectations in check, yeah?

So, to wrap it up, HIMS is in a bit of a tug-of-war between new opportunities and some challenges. It’s definitely a wait-and-see moment. Just remember, this is all for info and fun, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません